During the past decade, Dana-Farber Cancer Institute at St. Elizabeth's Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dana-Farber Cancer Institute at St. Elizabeth's Medical Center" #1 collaborator was "Ambry Genetics" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Gateway for Cancer Research" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Dana-Farber Cancer Institute at St. Elizabeth's Medical Center" are "Breast Cancer" (3 trials), "Gastrointestinal Cancer" (1 trials), "HER2-positive Breast Cancer" (1 trials), "Hematologic Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Dana-Farber Cancer Institute at St. Elizabeth's Medical Center" in a lesser frequency.

Most popular intervention types in "Dana-Farber Cancer Institute at St. Elizabeth's Medical Center" are "Drug" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "Educational Video" (1 trials), "Fulvestrant" (1 trials), "Paclitaxel" (1 trials) and "Palbociclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dana-Farber Cancer Institute at St. Elizabeth's Medical Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Dana-Farber Cancer Institute at St. Elizabeth's Medical Center". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Dana-Farber Cancer Institute at St. Elizabeth's Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dana-Farber Cancer Institute at St. Elizabeth's Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".